Toripalimab Combined With Surufatinib for Locally Advanced Thyroid Cancer: a Phase II Study
Clinical trial NCT04524884 · UNKNOWN
Trial details
- NCT number
- NCT04524884
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2022-04-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.